Initial combination therapy with radiation therapy (RT) and Nd: Yag laser photoresection for inoperable non-small cell carcinoma of lung (NSCLC): A preliminary report

Lung Cancer ◽  
1986 ◽  
Vol 2 (1-2) ◽  
pp. 157-158
CHEST Journal ◽  
1986 ◽  
Vol 89 (6) ◽  
pp. 782-785 ◽  
Author(s):  
Michael S. Eichenhom ◽  
Paul A. Kvale ◽  
Veronica M. Miks ◽  
H. Gunter Seydel ◽  
Bruce Horowitz ◽  
...  

Author(s):  
James O. Gates ◽  
Rao V.P. Mantravadi ◽  
John N. Crawford ◽  
Deepchand Bajpai ◽  
John D. Trenkner ◽  
...  

1994 ◽  
Vol 62 (3-4) ◽  
pp. 193-199 ◽  
Author(s):  
Tim A. Ahles ◽  
Peter M. Silberfarb ◽  
Amy Chen Rundle ◽  
Jimmie C. Holland ◽  
Alice B. Kornblith ◽  
...  

Rare Tumors ◽  
2016 ◽  
Vol 8 (4) ◽  
pp. 176-178 ◽  
Author(s):  
Dale Alan Whitaker ◽  
Daniel H. Miller ◽  
Niveditha Jagadesh ◽  
Gerald W. Strong ◽  
Lauren Hintenlang ◽  
...  

Prostate cancer is the most common malignancy of men in the United States. Small-cell carcinoma (SCC), which typically presents as an aggressive lung malignancy, is a rare diagnosis within the setting of prostate cancer pathology. Due to its limited prevalence, little information regarding the treatment and prognosis of this disease in large populations is available. To date our current knowledge base is largely limited to case reports and retrospective case reviews. The mainstay of treatment for this particular histology most often involves a multimodality approach utilizing chemotherapy in conjunction with radiation therapy, androgen deprivation therapy, or prostatectomy. Here we present the case of an elderly 89-year-old Caucasian male who was diagnosed with SCC of the prostate. Despite proceeding with a course of definitive radiotherapy, the patient experienced rapid progression of disease and ultimately elected to discontinue radiation therapy and receive hospice care.


2020 ◽  
Vol 13 (1) ◽  
pp. 373-378 ◽  
Author(s):  
Yuri Nakao ◽  
Satoshi Tamauchi ◽  
Nobuhisa Yoshikawa ◽  
Shiro Suzuki ◽  
Hiroaki Kajiyama ◽  
...  

We report a case of recurrent small cell carcinoma of the uterine cervix that showed a complete response to paclitaxel, carboplatin, and bevacizumab (TC + Bev) combination therapy. Small cell carcinoma of the uterine cervix is extremely rare, with an incidence of only 1.3% in Japan, and a poor outcome. The patient was a 62-year-old woman with a chief complaint of irregular vaginal bleeding. Magnetic resonance imaging showed a 10-cm irregular mass from the uterine corpus’s posterior wall to the cervix. Abdominal total hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymph node sampling were performed for suspected uterine sarcoma. Histopathological findings revealed small cell carcinoma with lymph node metastasis. Although 6 cycles of etoposide + cisplatin were performed, para-aortic lymph node recurrence was found 3 months after chemotherapy. Subsequently, the patient received 8 cycles of TC + Bev, which eliminated the metastases. The patient is currently alive at 24 months.


Sign in / Sign up

Export Citation Format

Share Document